SLC25A30-AS1

Across TCGA pan-cancer cohorts, SLC25A30-AS1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated SLC25A30-AS1 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher SLC25A30-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated SLC25A30-AS1 expression acts as an unfavorable survival marker, although some lineages such as STAD and BRCA show a favorable association.

STAD, BRCA, and THYM are the cancer types where SLC25A30-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.771	0.547	<.001	112	view →
BRCA	OS	Tertile	All	0.960	0.891	<.001	68	view →
THYM	DFS	Median	All	0.890	0.645	.008	33	view →
KIRP	DFS	Tertile	IV	0.761	0.040	.026	27	view →
LIHC	OS	Quartile	All	0.858	0.691	<.001	26	view →
UCEC	DFS	Median	All	0.875	0.800	.011	24	view →
ACC	OS	Tertile	IV	0.884	0.260	.024	20	view →
ESCA	OS	Tertile	IV	0.143	0.674	.024	18	view →
LGG	OS	Quartile	All	0.949	0.831	<.001	12	view →
HNSC	DFS	Median	IV	0.421	0.268	.023	12	view →
DLBC	DFS	Median	III,IV	0.482	0.923	.013	6	view →
BLCA	OS	Tertile	IV	0.328	0.661	.044	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

SLC25A30-AS1–STAD (OS)

Open the STAD breakdown →